Browsing by Author "Henderson, A."

Now showing items 1-1 of 1

Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study

Henderson, A.; Paterson, D. L.; Chatfield, M. D.; Tambyah, P. A.; Lye, D. C.; De, P. P.; Lin, R. T. P.; Chew, K. L.; Yin, M.; Lee, T. H.; Yılmaz, Mesut; Çakmak, Rümeysa; Alenazi, T. H.; Arabi, Y. M; Falcone, M.; Bassetti, M.; Righi, E.; Ba, Rogers; Kanj, S. S.; Bhally, H.; Iredell, J.; Mendelson, M.; Boyles, T. H.; Looke, D. F. M.; Runnegar, N. J.; Miyakis, S.; Walls, G.; Ai Khamis, M.; Zikri, A.; Crowe, A.; Ingram, P. R.; Daneman, N. N.; Griffin, P.; Athan, E.; Roberts, L.; Beatson, S. A.; Peleg, A. Y.; Cottrell, K. K.; Bauer, M. J.; Tan, E.; Chaw, K.; Nimmo, G. R.; Harris-Brown, T.; Harris, P. N. A. (Oxford University Press, 2021)

Introduction: This study aims to assess the association of piperacillin/tazobactam and meropenem minimum inhibitory concentration (MIC) and beta-lactam resistance genes with mortality in the MERINO trial.Methods: Blood ...